MODERNA has won the latest round of its long-running legal battle with Pfizer and its German partner BioNTech over its Covid ...
Moderna said Friday that the European Patent Office has upheld the validity of one of its key patents, a victory in a ...
Moderna has won a case at the European Patent Office in its dispute with Pfizer and BioNTech over its COVID-19 vaccine, the ...
London: Moderna announced on Friday that it has emerged victorious in a case at the European Patent Office against Pfizer and ...
Moderna said on Friday the European Patent Office had upheld the validity of one of the company's key patents, a win in an ...
The European Patent Office last week upheld one of Moderna’s key patents, handing the biotech an important victory in its ...
NEW YORK (Reuters) – Moderna said on Friday the European Patent Office had upheld the validity of one of the company's key ...
Then $75 per month. Complete digital access to quality FT journalism on any device. Cancel anytime during your trial.
USA-based Moderna has won a case at the European Patent Office (EPO) in its dispute with Pfizer and BioNTech over its Covid-19 vaccine, in a boost for the mRNA-vaccine maker in its ongoing legal fight ...
The COVID-19 vaccine is currently being contested between Moderna Pfizer (PFE.N), which opens a new tab, and BioNTech ...
Moderna said on Friday the European Patent Office had upheld the validity of one of the company’s key patents, a win in an ...
Moderna said that the European Patent Office had decided to maintain the validity of one of the company's key patents ...